The Food and Drug Administration (FDA) is asking recovered COVID-19 patients to donate plasma to assist in the development of blood-related therapies.
People who have fully recovered from the CCP (Chinese Communist Party) virus have antibodies in their blood to ward off future infections, and plasma can help make treatments for severely ill patients, according to the agency.
